1. Circulating tumour DNA is a potential biomarker for disease progression and response to targeted therapy in advanced thyroid cancer. (November 2018) Authors: Allin, D.M.; Shaikh, R.; Carter, P.; Thway, K.; Sharabiani, M.T.A.; Gonzales-de-Castro, D.; O'Leary, B.; Garcia-Murillas, I.; Bhide, S.; Hubank, M.; Harrington, K.; Kim, D.; Newbold, K. Journal: European journal of cancer Issue: Volume 103(2018) Page Start: 165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DNMT3A‐2 EXPRESSION LEVELS CHARACTERISE DIFFUSE LARGE B‐CELL LYMPHOMA WITH DISTINCT METHYLATION PATTERNS AND OUTCOME. (June 2017) Authors: Kuhnl, A.; Shaikh, R.; Cunningham, D.; Counsell, N.; Barrans, S.; Burton, C.; Bentley, M.; Gleeson, M.; Edwards, L.; Ulrich, L.; Smith, P.; Clifton‐Hadley, L.; Schofield, O.; Lawrie, A.; Linch, D.; Hubank, M.; Kaiser, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Reconstructing gene networks: what are the limits?. (1st December 2003) Authors: Stark, J.; Brewer, D.; Barenco, M.; Tomescu, D.; Callard, R.; Hubank, M. Journal: Biochemical Society transactions Issue: Volume 31:Number 6(2003) Page Start: 1519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗